Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher McCabe

Showing results (11-20 of 150) with videos related to

Pageof 15
Sort By:
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|January 11, 2018
Pitfalls of prioritizing cost-effectiveness in the assessment of medical innovation: A comment on Wallis and Detsky guest editorialMike Paulden, Christopher Mccabe
Pharmacoeconomics|January 31, 2021
Modifying NICE's Approach to Equity WeightingMike Paulden, Christopher McCabe
BMJ (Clinical Research Ed.)|July 15, 2011
A full blooded market system: at what cost to the NHS?Ian Kirkpatrick, Christopher McCabe
Pharmacoeconomics|February 26, 2013
What evidence is there for the reimbursement of personalised medicine?Peter S Hall, Christopher McCabe
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 31, 2008
Modeling HUI 2 health state preference data using a nonparametric Bayesian methodSamer A Kharroubi, Christopher McCabe
Advances in Experimental Medicine and Biology|September 9, 2010
Economic considerations in the provision of treatments for rare diseasesChristopher McCabe, Richard Edlin, Jeff Round
BMJ (Clinical Research Ed.)|September 24, 2010
Is it time to revisit orphan drug policies?Christopher McCabe, Tania Stafinski, Devidas Menon
International Journal of Technology Assessment in Health Care|April 11, 2008
Why licensing authorities need to consider the net value of new drugs in assigning review priorities: addressing the tension between licensing and reimbursementChristopher McCabe, Karl Claxton, Anthony O'Hagan
Pharmacoeconomics|July 24, 2013
Navigating time and uncertainty in health technology appraisal: would a map help?Christopher McCabe, Richard Edlin, Peter Hall
Medical Decision Making : an International Journal of the Society for Medical Decision Making|August 25, 2016
Determinants of Change in the Cost-effectiveness ThresholdMike Paulden, James O'Mahony, Christopher McCabe
Pageof 15

Showing results (11-20 of 150) with videos related to

Sort By:
Pageof 15
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|January 11, 2018
Pitfalls of prioritizing cost-effectiveness in the assessment of medical innovation: A comment on Wallis and Detsky guest editorialMike Paulden, Christopher Mccabe
Pharmacoeconomics|January 31, 2021
Modifying NICE's Approach to Equity WeightingMike Paulden, Christopher McCabe
BMJ (Clinical Research Ed.)|July 15, 2011
A full blooded market system: at what cost to the NHS?Ian Kirkpatrick, Christopher McCabe
Pharmacoeconomics|February 26, 2013
What evidence is there for the reimbursement of personalised medicine?Peter S Hall, Christopher McCabe
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 31, 2008
Modeling HUI 2 health state preference data using a nonparametric Bayesian methodSamer A Kharroubi, Christopher McCabe
Advances in Experimental Medicine and Biology|September 9, 2010
Economic considerations in the provision of treatments for rare diseasesChristopher McCabe, Richard Edlin, Jeff Round
BMJ (Clinical Research Ed.)|September 24, 2010
Is it time to revisit orphan drug policies?Christopher McCabe, Tania Stafinski, Devidas Menon
International Journal of Technology Assessment in Health Care|April 11, 2008
Why licensing authorities need to consider the net value of new drugs in assigning review priorities: addressing the tension between licensing and reimbursementChristopher McCabe, Karl Claxton, Anthony O'Hagan
Pharmacoeconomics|July 24, 2013
Navigating time and uncertainty in health technology appraisal: would a map help?Christopher McCabe, Richard Edlin, Peter Hall
Medical Decision Making : an International Journal of the Society for Medical Decision Making|August 25, 2016
Determinants of Change in the Cost-effectiveness ThresholdMike Paulden, James O'Mahony, Christopher McCabe
Pageof 15